February 18, 2022
Recipharm acquires Vibalogics and Arranta Bio
Recipharm, a global contract development and manufacturing organisation (CDMO), has announced the acquisition of Vibalogics, a virotherapy CDMO and a…
Pharmaceuticals, Biotechnology and Life Sciences
Recipharm, a global contract development and manufacturing organisation (CDMO), has announced the acquisition of Vibalogics, a virotherapy CDMO and a…